Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

FED × Prostatic Neoplasms × Cholecalciferol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

pembrolizumab 3 enzalutamide 3 Testosterone 2 Docetaxel 2 Celecoxib 2 Abiraterone Acetate 2 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2 gallium 68 PSMA-11 1 capivasertib 1 apalutamide 1 Yoga 1 Tablets 1 Simvastatin 1 Sildenafil Citrate 1 Pluvicto 1 Perioperative Care 1 Pentoxifylline 1 Ketoconazole 1 Hydroxymethylglutaryl-CoA Reductase Inhibitors 1 Fecal Microbiota Transplantation 1 Estramustine 1 Epirubicin 1 Drug Therapy 1 Cholecalciferol 1 Androgen Antagonists 1 Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01759771 2024-03-18

VD3PCa

VA Office of Research and Development

Phase 2 Completed

130 enrolled 13 charts

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡